Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Non-Current Assets: 2017-2021

Historic Non-Current Assets for Cogent Biosciences (COGT) over the last 4 years, with Sep 2021 value amounting to $7.9 million.

  • Cogent Biosciences' Non-Current Assets rose 22.11% to $7.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $7.9 million, marking a year-over-year increase of 22.11%. This contributed to the annual value of $6.0 million for FY2020, which is 32.02% down from last year.
  • As of Q3 2021, Cogent Biosciences' Non-Current Assets stood at $7.9 million, which was up 9.98% from $7.2 million recorded in Q2 2021.
  • Cogent Biosciences' 5-year Non-Current Assets high stood at $11.4 million for Q1 2019, and its period low was $4.9 million during Q4 2018.
  • Moreover, its 3-year median value for Non-Current Assets was $7.8 million (2020), whereas its average is $8.1 million.
  • In the last 5 years, Cogent Biosciences' Non-Current Assets skyrocketed by 90.84% in 2019 and then crashed by 34.85% in 2020.
  • Over the past 5 years, Cogent Biosciences' Non-Current Assets (Quarterly) stood at $6.7 million in 2017, then declined by 26.89% to $4.9 million in 2018, then soared by 79.33% to $8.8 million in 2019, then plummeted by 32.02% to $6.0 million in 2020, then climbed by 22.11% to $7.9 million in 2021.
  • Its Non-Current Assets stands at $7.9 million for Q3 2021, versus $7.2 million for Q2 2021 and $5.5 million for Q1 2021.